Sky View Investment Advisors, LLC Gilead Sciences, Inc. Transaction History
Sky View Investment Advisors, LLC
- $627 Million
- Q4 2024
A detailed history of Sky View Investment Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 7,846 shares of GILD stock, worth $863,766. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,846
Previous 8,482
7.5%
Holding current value
$863,766
Previous $711,000
1.97%
% of portfolio
0.12%
Previous 0.12%
Shares
14 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.9 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.55 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.01 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.9 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...